₹ 2,671.10
76.20 (2.94%)
G
Glenmark Pharmaceuticals
₹ 2,671.10
Glenmark Pharmaceuticals EPS Summary (consolidated)
The latest quarterly EPS of Glenmark Pharmaceuticals as of Q2 Sep 2026 stands at ₹9.35. This is a 45.35% fall quarter on quarter and 56.77% fall same quarter last year. For the FY2026 the EPS of Glenmark Pharmaceuticals stands at ₹48.26. This is a 30.05% growth compared with FY2025.
Glenmark Pharmaceuticals EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

